Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Clinical trial NCT05965284 · RECRUITING
Trial details
- NCT number
- NCT05965284
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2025-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.